Darbepoetin alfa
Top View
- Specialty Drug List
- DARBEPOETIN ALFA, EPOETIN ALFA, and METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA Policy Number: PHARMACY 080.29 T2 Effective Date: October 1, 2017
- Injections: Drugs AD Policy
- Clinical Pharmacology Biopharmaceutics Review(S)
- Aranesp Medication Guide
- Pub 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 2582 Date: November 2, 2012 Change Request 8050
- Aranesp (Darbepoetin Alfa) Is an Erythropoiesis-Stimulating Protein That Is Produced in Chinese Hamster Ovary (CHO) Cells by Recombinant DNA Technology
- The Use of Erythropoiesis-Stimulating Agents With
- Omontys, INN-Peginesatide
- Aranesp® (Darbepoetin Alfa) Injection
- Aranesp® (Darbepoetin Alfa)
- Article Peginesatide for Maintenance Treatment of Anemia In
- A Phase 3 Randomized Placebo-Controlled Trial of Darbepoetin Alfa in Patients with Anemia and Lower-Risk Myelodysplastic Syndromes
- Mircera (Methoxy Polyethylene Glycol-Epoetin
- Darbepoetin Alfa, Aranesp, Amgen Package Insert
- Difference for ME.”
- Aranesp® (Darbepoetin Alfa) Injection
- Aranesp®(Darbepoetin Alfa)